MeSH tree: E02
A small group of patients with an otherwise incurable form of T‑cell leukemia have seen their cancer driven into remission by an innovative form of immune therapy.
Dec 10, 2025
0
0
From 2003 to 2022, there was a more than doubling in low-capability pediatric hospitals, according to a study published online Dec. 10 in Pediatrics.
Dec 10, 2025
0
0
For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five years, according to a ...
Dec 10, 2025
0
0
Researchers from the Keck School of Medicine of USC have developed a new type of chimeric antigen receptor (CAR) T cell that elicits a more controlled immune response to cancer in mice—effectively killing cancer cells, ...
Dec 10, 2025
0
5
Socioeconomic vulnerability and multiple medical comorbidities are risk factors for late-onset depression among long-term cancer survivors, according to a study published in JAMA Network Open.
Dec 10, 2025
0
0
A night-shift worker finishes at dawn. Their phone says Tuesday, but their body feels like it's Monday. The body's internal clock, or circadian rhythm, controls physiological processes such as sleeping, eating and physical ...
Dec 10, 2025
0
0
A new major study from Queen Mary University of London has found that smokers who use both cigarettes and e-cigarettes at the same time—known as dual use—are reducing their intake of harmful chemicals and are also more ...
Dec 10, 2025
0
0
When neurologist Steven Arnold is deciding whether to treat an Alzheimer's patient with a new therapy, he relies on averages.
Dec 9, 2025
0
0
Recovering from respiratory syncytial virus often doesn't end when it's time to leave the hospital, even for younger adults.
Dec 9, 2025
0
0
The ethical and artistic debates aside, there are good reasons for research into artificial-intelligence systems that can generate music. A new system described in the International Journal of Arts and Technology has improved ...
Dec 9, 2025
0
0
